
Bio Green Med Solution fell 53.5% from $1.44 to $0.67, behind the S&P 500's +10.8%. Its worst day was Jun 8 (−26.7%), and its low came Jun 26 at $0.60.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.31 was reported on $81,000.00 revenue.
−2.2% · S&P 500 0.0%
Bio Green Med Solution closed at its highest level of the year, 26.4% above where the year started.
Story events cover the past 12 months · Times ET
+7.7% · S&P 500 +0.1%
Bio Green Med Solution shares rose 33.7%, while the S&P 500 rose 1.9%.
+33.7% · S&P 500 +1.9%
EPS of $-2.21 was reported on $666,000.00 revenue.
+6.9% · S&P 500 +2.9%
Bio Green Med Solution shares fell 20.5%, while the S&P 500 fell 0.4%.
−20.5% · S&P 500 −0.4%
EPS of $-0.04 was reported on $778,000.00 revenue.
−5.1% · S&P 500 −1.2%
Bio Green Med Solution shares rose 41.5%, while the S&P 500 fell 2.6%.
+41.5%, the year's best day, on 105M shares, the year's heaviest volume · S&P 500 −2.6%
Bio Green Med Solution closed at its lowest level of the year, 58.3% below where the year started.
0.0% · S&P 500 −0.7%
EPS of $-0.08 was reported on $336,000.00 revenue.
−3.0% · S&P 500 +0.7%
Bio Green Med Solution shares rose 19.0%, while the S&P 500 fell 0.1%.
+19.0% · S&P 500 −0.1%
Where it ended: a close of $0.67 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026.
Nothing in the past 12 months.
All BGMS analyst actionsNothing in the past 12 months.
All BGMS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BGMS and SPY from Benzinga historical bars. Not investment advice.